There’s no “silver bullet” for this problem, which is largely driven by clinical inertia, but some efforts are chipping away ...
Several observations from preclinical and short-term clinical studies support a role for sildenafil in the treatment of heart failure patients. The following discussion briefly considers each of ...
Heart failure is a disorder that predominantly affects ... and to provide specific recommendations for the pharmacologic treatment of HF in the elderly.
Noninvasive liver fibrosis scores are associated with increased heart failure risk, with FIB-4, NFS, and APRI showing ...
A new single-dose treatment demonstrates potential for improving heart repair following heart attacks in preclinical studies. Researchers at the Eli and Edythe Broad Center of Regenerative Medicine an ...
Welcome, everyone, to this roundtable discussion on heart failure ... the goal of treatment is trying to improve the heart function with beta blockers, either ACE or ARNI. We also know about ...
"Even though this trial was not designed to test this treatment in heart failure, there are hints in the data that the monoclonal antibody might be beneficial for patients with heart failure ...
FineHeart, a clinical-stage MedTech company developing innovative medical devices for heart failure, has achieved a major milestone in its ...
Heart failure is an increasingly common and fatal disease and causes a heavy patient, health care–system, and cost burden. A cost-effectiveness study looking at different scenarios of achieving ...
Those are much more rare. (A cardiomyopathy is simply a disease of the heart.) Once we determine causes, then we can get a better idea of treatment. We break treatment down into categories.
How Heart Patients Can Benefit From a Single-Dose Treatment Signs of Cardiovascular Disease Are Different in Men and Women—How to Recognize Common Symptoms What Are the Symptoms and Early Signs ...
Oct. 30, 2024 — Chronic, low-level lead poisoning is a major risk factor for cardiovascular disease in adults and cognitive deficits in children, even at levels previously thought to be safe ...